Hey there! Welcome!
Get updated on
Select Speciality
Top Picks
30 Jul, 26
The second Universal Definition of heart failure (HF) standardizes HF terminology, reclassifies HF phenotypes beyond rigid EF cutoffs, emphasizes pre-HF detection, social determinants, & global disparities to improve prevention, diagnosis, & care.
14 Jul, 26
ESHRE 2026
Key highlights of the sessions on global and socio-cultural aspects of infertility presented at ESHRE from 5th to 8th July 2026 in London, UK.
3 Aug, 26Eur J Prev Cardiol.
- Among 124360 MI patients (21% diabetics), obesity was more prevalent in diabetics (37% vs 20%)
- Over a mean of 6 yrs, class 3 obesity with diabetes raised risk of all-cause mortality (HR 2.15) & MACE (HR 1.91), class 3 obesity alone raised MACE risk by 29%, risks were driven more by HF (HR 2.92) & renal events (HR 3.36) than atherosclerotic events
- Severe obesity & diabetes adversely impact prognosis post-MI.
3 Aug, 26Int J COPD
- In a UK Biobank cohort of 28,251 older adults, digital gait biomarkers derived from wrist-worn accelerometers predicted incident COPD over 8.5 years
- Reduced mobility measures were independently associated with higher COPD risk
- A prediction model combining gait metrics with basic clinical factors achieved strong accuracy, offering a practical, automated approach for early COPD risk detection and intervention.
30 Jul, 26Diabetologia.
- A multinational cross-sectional analysis was conducted in 20,822 T2DM patients (from AusDiab, NHANES, Mauritius survey, & ICMR-INDIAB)
- Younger patients had higher BMI, triglycerides, LDL-C, & lower HDL-C, implying a more adverse cardiometabolic profile, FPG & HbA1c peaked at ~45–60 yrs before declining, older adults had higher SBP & UACR
- Glycemic & lipid abnormalities were more pronounced at younger ages.
29 Jul, 26Diabetes Ther.
- 1072 patients with T2DM & CKD were followed for 60.4 months to assess the link between time-averaged serum uric acid (TA-SUA) & renal outcomes
- Maintaining TA-SUA <360 μmol/L was associated with better renal survival & a 37% lower risk of adverse renal outcomes vs TA-SUA ≥360 μmol/L (aHR:0.63)
- Renal risk increased sharply above 360 μmol/L, the greatest benefit observed in patients with eGFR 30–59 mL/min/1.73 m²
31 Jul, 26
Featured
3 Aug, 26
27 Jul, 26
27 Jul, 26
